Prevention of Left Ventricular Dysfunction During Chemotherapy

Summary

Prevention of Left Ventricular Dysfunction During Chemotherapy is a clinical trial^[1].

Key Facts

• Prevention of Left Ventricular Dysfunction During Chemotherapy is in the country of Spain^[2].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's instance of is recorded as clinical trial^[3].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's start time is recorded as +2008-04-30T00:00:00Z^[4].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's end time is recorded as +2011-12-31T00:00:00Z^[5].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's main subject is recorded as ventricular dysfunction^[6].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's main subject is recorded as multiple myeloma^[7].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's main subject is recorded as leukemia^[8].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's main subject is recorded as lymphoma^[9].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's number of participants is recorded as {'unit': '1', 'amount': '+90'}^[10].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's title is recorded as Prevention of Left Ventricular Dysfunction With Enalapril and Carvedilol in Patients Submitted to Intensive Chemotherapy for the Treatment of Malignant Hemopathies^[11].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's short name is recorded as OVERCOME^[12].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[13].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's ClinicalTrials.gov ID is recorded as NCT01110824^[14].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+70'}^[15].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's research intervention is recorded as carvedilol^[16].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's research intervention is recorded as enalapril / hydrochlorothiazide^[17].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's clinical trial phase is recorded as phase III clinical trial^[18].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's research site is recorded as University of Barcelona^[19].
• Prevention of Left Ventricular Dysfunction During Chemotherapy's study type is recorded as interventional study^[20].